Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus II Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07124559
What this trial is testing

Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 144
Testing effectiveness (Phase 2)UnknownNCT00131560
What this trial is testing

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Who this might be right for
HIV Infection
VIRxSYS Corporation 60
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT02165202
What this trial is testing

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus (HIV)
PATH 136
Early research (Phase 1)Study completedNCT00000837
What this trial is testing

The Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 127
Testing effectiveness (Phase 2)Study completedNCT00091702
What this trial is testing

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Who this might be right for
HIV InfectionsInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00001058
What this trial is testing

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 246
Testing effectiveness (Phase 2)Study completedNCT00000671
What this trial is testing

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 750
Testing effectiveness (Phase 2)Study completedNCT01717287
What this trial is testing

The Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 32
Testing effectiveness (Phase 2)Study completedNCT05056974
What this trial is testing

A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs

Who this might be right for
HIV-1 Infection
United BioPharma 11
Testing effectiveness (Phase 2)Study completedNCT02457689
What this trial is testing

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

Who this might be right for
HIV
Imperial College London 30
Testing effectiveness (Phase 2)Ended earlyNCT02972450
What this trial is testing

An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 1
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Study completedNCT02738502
What this trial is testing

Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors

Who this might be right for
Maternal-fetal Infection Transmission
ANRS, Emerging Infectious Diseases 91
Testing effectiveness (Phase 2)Study completedNCT00004400
What this trial is testing

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Who this might be right for
HIV InfectionsCachexia
Charles Drew University of Medicine and Science 56
Testing effectiveness (Phase 2)Study completedNCT00002169
What this trial is testing

Viracept in AIDS Patients With Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Agouron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT03224338
What this trial is testing

Dolutegravir Plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects

Who this might be right for
HIV II Infection
Blueclinical, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00002233
What this trial is testing

A Combination of Four Drugs in Patients With Recent HIV Infection

Who this might be right for
HIV Infections
Glaxo Wellcome 30
Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Testing effectiveness (Phase 2)UnknownNCT04444674
What this trial is testing

COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection

Who this might be right for
Coronavirus
University of Oxford 2,130
Next Page